Form SD DOUGLAS DYNAMICS, INC
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form SD
Specialized Disclosure Report
DOUGLAS DYNAMICS, INC.
(Exact name of the registrant as specified in its charter)
|
Delaware |
001-34728 |
13-4275891 |
|
(State or other jurisdiction |
(Commission file number) |
(I.R.S. Employer Identification No.) |
|
11270 W Park Place Ste 300, Milwaukee, Wisconsin |
53224 |
|
(Address of principal executive offices) |
(Zip code) |
|
Sarah Lauber |
(414) 354-2310 |
|
(Name and telephone number, including area code, of the |
|
Check the appropriate box to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:
|
☒ |
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2025. |
|
☐ |
Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended __________. |
Section 1 - Conflict Minerals Disclosure
Items 1.01 and 1.02 Conflict Minerals Disclosure and Report; Exhibit
Douglas Dynamics, Inc. (the “Company”) is filing a Conflict Minerals Report as Exhibit 1.01 hereto. Together with this disclosure, the Conflict Minerals Report will be made publicly available in the Investor Relations section of the Company’s investor relations website at https://ir.douglasdynamics.com as of the date of this filing.
Section 2 – Resource Extraction Issuer Disclosure
Item 2.01 Resource Extraction Issuer Disclosure and Report
Not applicable.
Section 3 – Exhibits
Item 3.01 Exhibits
Exhibit 1.01 – Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
DOUGLAS DYNAMICS, INC.
| /s/ Sarah C. Lauber | May 15, 2026 |
| By Sarah C. Lauber | (Date) |
| Executive Vice President, Chief Financial Officer and Secretary |
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
- Author Fari Presents Cambodia's Path to Peace and Stability in New Book on Hun Sen's Leadership
- Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share